DHZC-2 Tablet by Ton Shen Health: Recall – Possible Health Risk
ISSUE:
Ton Shen Health of Chicago, IL, is recalling its “DHZC-2” Tablets because they have the potential to be contaminated with elevated levels of lead, a naturally occurring element which can affect multiple body system and particularly harmful to young children. Lead poisoning can happen if a person is exposed to high levels of lead over short period of time.One illness has been reported to date in connection with this problem.
BACKGROUND:
The recalled “DHZC-2” tablets were mostly sold locally in Chicago area in retails stores and some were distributed to other states through mail orders. The product comes in a 1.6 ounce, white plastic package marked with lot # 2163-844 on the bottom. UPC: 616042102727. The potential for contamination was noted after FDA notice of higher level of lead presence in DHZC-2 samples. The sale of the product has been suspended and inventory put on hold while FDA and the company continue to investigate the source of the problem.
Click here to read the MedWatch Safety Alert, including a link to the Firm Press Release.
Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!
